Seqens – API Manufacturing Capabilities

PCI is a fully integrated Active Pharmaceutical Ingredient (API) manufacturer and custom synthesis supplier. We’ll be with you every step of the way as you develop your final API or chemical product.

Posted: April 6, 2017

Author:
Tags: API Manufacturing | Video
API Manufacturing and Pharmaceutical Manufacturing

 

Related posts:

Dealing with Tariffs and Other Uncertainties
Tech Transfer from a Project Management Perspective
Are You Implementing a “Right-First-Time” Approach to Synthetic Route Selection for APIs?
If DCAT Week was Any Indication, Bright Times Ahead for CDMO Marketplace
Generic API Margins Being Squeezed?

About the Author

Ed Price CEO of PCI Synthesis
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...

Do you have questions? Talk to Ed.